20-21334125-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012255.5(XRN2):āc.1173G>Cā(p.Met391Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00045 in 1,613,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00031 ( 0 hom., cov: 32)
Exomes š: 0.00046 ( 0 hom. )
Consequence
XRN2
NM_012255.5 missense
NM_012255.5 missense
Scores
3
2
14
Clinical Significance
Conservation
PhyloP100: 5.05
Genes affected
XRN2 (HGNC:12836): (5'-3' exoribonuclease 2) This gene encodes a 5'-3' exonuclease that promotes transcription termination at cotranscriptional cleavage sites. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04387006).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XRN2 | NM_012255.5 | c.1173G>C | p.Met391Ile | missense_variant | 13/30 | ENST00000377191.5 | NP_036387.2 | |
XRN2 | NM_001317960.1 | c.1407G>C | p.Met469Ile | missense_variant | 13/30 | NP_001304889.1 | ||
XRN2 | XM_017027722.2 | c.1407G>C | p.Met469Ile | missense_variant | 13/17 | XP_016883211.1 | ||
XRN2 | XM_017027723.3 | c.-124G>C | 5_prime_UTR_variant | 1/18 | XP_016883212.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XRN2 | ENST00000377191.5 | c.1173G>C | p.Met391Ile | missense_variant | 13/30 | 1 | NM_012255.5 | ENSP00000366396 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152210Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
47
AN:
152210
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000311 AC: 78AN: 250994Hom.: 0 AF XY: 0.000339 AC XY: 46AN XY: 135624
GnomAD3 exomes
AF:
AC:
78
AN:
250994
Hom.:
AF XY:
AC XY:
46
AN XY:
135624
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000465 AC: 679AN: 1461614Hom.: 0 Cov.: 32 AF XY: 0.000415 AC XY: 302AN XY: 727102
GnomAD4 exome
AF:
AC:
679
AN:
1461614
Hom.:
Cov.:
32
AF XY:
AC XY:
302
AN XY:
727102
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000309 AC: 47AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74488
GnomAD4 genome
AF:
AC:
47
AN:
152328
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
7
ExAC
AF:
AC:
44
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2022 | The c.1173G>C (p.M391I) alteration is located in exon 13 (coding exon 13) of the XRN2 gene. This alteration results from a G to C substitution at nucleotide position 1173, causing the methionine (M) at amino acid position 391 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of catalytic residue at A395 (P = 0.1551);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at